Fulgent Genetics Price to Sales Ratio 2015-2023 | FLGT
Historical PS ratio values for Fulgent Genetics (FLGT) over the last 10 years. The current P/S ratio for Fulgent Genetics as of May 01, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Fulgent Genetics P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-05-01 | 20.70 | 2.13 | |
| 2023-12-31 | 28.91 | $9.71 | 2.98 |
| 2023-09-30 | 26.74 | $9.52 | 2.81 |
| 2023-06-30 | 37.03 | $10.13 | 3.66 |
| 2023-03-31 | 31.22 | $11.87 | 2.63 |
| 2022-12-31 | 29.78 | $19.88 | 1.50 |
| 2022-09-30 | 38.12 | $25.82 | 1.48 |
| 2022-06-30 | 54.53 | $29.71 | 1.84 |
| 2022-03-31 | 62.41 | $30.67 | 2.03 |
| 2021-12-31 | 100.59 | $32.10 | 3.13 |
| 2021-09-30 | 89.95 | $36.24 | 2.48 |
| 2021-06-30 | 92.23 | $33.25 | 2.77 |
| 2021-03-31 | 96.62 | $29.02 | 3.33 |
| 2020-12-31 | 52.10 | $17.70 | 2.94 |
| 2020-09-30 | 40.04 | $5.88 | 6.81 |
| 2020-06-30 | 16.00 | $2.09 | 7.64 |
| 2020-03-31 | 10.76 | $1.78 | 6.04 |
| 2019-12-31 | 12.90 | $1.72 | 7.51 |
| 2019-09-30 | 10.39 | $1.58 | 6.56 |
| 2019-06-30 | 6.68 | $1.37 | 4.89 |
| 2019-03-31 | 5.95 | $1.22 | 4.86 |
| 2018-12-31 | 3.17 | $1.19 | 2.66 |
| 2018-09-30 | 3.93 | $1.12 | 3.52 |
| 2018-06-30 | 4.14 | $1.06 | 3.92 |
| 2018-03-31 | 4.00 | $1.02 | 3.93 |
| 2017-12-31 | 4.38 | $1.05 | 4.18 |
| 2017-09-30 | 4.79 | $1.23 | 3.88 |
| 2017-06-30 | 6.39 | $1.37 | 4.66 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.608B | $0.289B |
| Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $34.790B | 19.11 |
| Inspire Medical Systems (INSP) | United States | $7.322B | 0.00 |
| 10x Genomics (TXG) | United States | $3.489B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.410B | 0.00 |
| Axonics (AXNX) | United States | $3.396B | 0.00 |
| Enovis (ENOV) | United States | $3.029B | 23.01 |
| Azenta (AZTA) | United States | $2.925B | 238.46 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.864B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.685B | 0.00 |
| Privia Health (PRVA) | United States | $2.183B | 96.84 |
| Schrodinger (SDGR) | United States | $1.763B | 0.00 |
| Omnicell (OMCL) | United States | $1.231B | 30.12 |
| Phreesia (PHR) | United States | $1.169B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.817B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.783B | 0.00 |
| Standard BioTools (LAB) | United States | $0.719B | 0.00 |
| Talkspace (TALK) | United States | $0.519B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.367B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.333B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.312B | 0.00 |
| Pulmonx (LUNG) | United States | $0.293B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.170B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.162B | 0.00 |
| American Well (AMWL) | United States | $0.148B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.139B | 0.00 |
| Augmedix (AUGX) | United States | $0.133B | 0.00 |
| Outset Medical (OM) | United States | $0.131B | 0.00 |
| TruBridge (TBRG) | United States | $0.116B | 4.94 |
| 111 (YI) | China | $0.087B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.073B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.071B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.047B | 0.00 |
| Movano (MOVE) | United States | $0.044B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.031B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.025B | 0.00 |
| Cue Health (HLTH) | United States | $0.022B | 0.00 |
| CareCloud (CCLD) | United States | $0.018B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.018B | 0.00 |
| ETAO (ETAO) | United States | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Biotricity (BTCY) | United States | $0.013B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |